Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

61.77
Delayed Data
As of Feb 17
 +0.29 / +0.47%
Today’s Change
53.35
Today|||52-Week Range
68.12
-1.36%
Year-to-Date
Green Square Capital Llc Buys Landmark Infrastructure Partners LP, iShares Short-Term...
Feb 17 / GuruFocus News - Paid Partner Content
3 Top Biotech Stocks to Buy on Sale
Feb 13 / MotleyFool.com - Paid Partner Content
Pfizer's Xeljanz Combo Comparable to AbbVie's Humira
Feb 17 / Zacks.com - Paid Partner Content
Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017
Feb 10 / MotleyFool.com - Paid Partner Content
Hikari Tsushin, Inc. Buys Roper Technologies, Sells Coca-Cola Co, Alphabet, Johnson &...
Feb 16 / GuruFocus News - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly
Feb 10 / MotleyFool.com - Paid Partner Content
Marco Investment Management Llc Buys Johnson Controls International PLC, Amgen, AbbVi...
Feb 16 / GuruFocus News - Paid Partner Content
3 Trump-Proof Dividend Stocks to Buy Right Now
Feb 09 / MotleyFool.com - Paid Partner Content
Partner Investment Management, L.P. Buys Anthem, Cigna, AbbVie, Sells Apple, Baxter ....
Feb 16 / GuruFocus News - Paid Partner Content
Why OraSure Technologies, Inc. Leaped Higher Today
Feb 09 / MotleyFool.com - Paid Partner Content
Why I Just Bought AbbVie Stock
Feb 15 / MotleyFool.com - Paid Partner Content
Gilead (GILD) Beats Q4 Earnings & Sales, View Disappoints
Feb 08 / Zacks.com - Paid Partner Content
Eli Lilly Is Great Stock to Buy Now
Feb 15 / TheStreet.com - Paid Partner Content
Gilead Sciences Just Shocked Investors, And It Wasn't Good
Feb 08 / MotleyFool.com - Paid Partner Content
No Joke: Johnson & Johnson Could Grow Sales by 5% (or More) Annually Over the Next De...
Feb 15 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Apple, Visa and AbbVie
Feb 08 / Zacks.com - Paid Partner Content
Gilead (GILD) Announces Data on Combination Therapy for HIV
Feb 14 / Zacks.com - Paid Partner Content
Earnings No Longer a Headwind for Stocks
Feb 07 / Zacks.com - Paid Partner Content
Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More
Feb 13 / Zacks.com - Paid Partner Content